Holding(s) in Company
TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00BWXC7Y93 Issuer Name Fidelity Special Values PLC UK or Non-UK Issuer UK 2. Reason for Notification An acquisition or disposal of voting rights 3. Details of person subject to the notification obligation Name Evelyn Partners Limited City of registered office (if applicable) London Country of registered office (if applicable) United Kingdom 4. Details of the shareholder Full name of shareholder(s) if different from the person(s) subject to the notification
Company release, Inside information11 September 2023 at 12:30 (EEST)
Nightingale Health Plc’s (“Nightingale Health”) Board of Directors has approved an updated strategy which focuses on business to business (“B2B”) and business to governments (“B2G”) markets. The updated strategy builds on the significant contracts that the company has recently won and market feedback about the company’s strengths. Moreover, the updated strategy allows Nightingale Health to better focus and allocate its resources around its core intellectual property assets, competencies, and value creation
